WHO chief arrives in DRC to address Ebola outbreak as response faces conflict, funding hurdles

The Story

WHO Director-General Tedros Adhanom Ghebreyesus arrived in the Democratic Republic of the Congo on May 28 to support containment of an Ebola outbreak caused by the rare Bundibugyo strain. The outbreak, centered in the conflict-affected Ituri province, has recorded over 1,000 suspected cases and more than 200 suspected deaths. Health officials report no approved treatment or vaccine for this strain, and the response is complicated by armed groups, displacement, and community distrust.

Key Facts

• WHO Director-General Tedros Adhanom Ghebreyesus arrived in Kinshasa on May 28 and planned to travel to the outbreak center in Ituri province.
• The outbreak is caused by the Bundibugyo strain of Ebola, which has no approved treatment or vaccine.
• The outbreak is centered in Ituri province, with cases also reported in North and South Kivu provinces.
• Tedros called for a ceasefire in the conflict-affected region to aid containment efforts.
• Uganda closed its border with the DRC in response to the outbreak.
• The United States has committed over $112 million in total aid for the regional response, including additional funds announced on May 28.
• The US plans to send Americans exposed to Ebola to a new facility in Kenya.
• Armed groups, including the M23 and Allied Democratic Forces, are active in the outbreak region.
• The WHO discourages travel bans, stating they can hinder containment.

Conflicting Reports

• Death rate: The Guardian reports that the WHO estimates the death rate at 30-50% based on confirmed cases. NPR does not report a specific death rate but notes 238 suspected deaths out of 1,077 suspected cases, which implies a lower rate. The two sources may reflect different case definitions.
• US aid specifics: The Guardian reports that the US pledged an additional $13.5 million toward Kenya’s Ebola preparedness on top of $112 million already pledged. NPR reports that the US announced $80 million in additional aid, bringing total commitments to more than $112 million. The amounts of additional aid differ.
• US travel restrictions: The Guardian reports that the US said it would deny entry to anyone infected with the disease. NPR reports that the Trump administration announced a temporary ban on entry of people without US passports or green cards who have visited DRC, Uganda, or South Sudan in the past 21 days.
• Displacement figures: The Guardian, citing the UN refugee agency, reports that 245,000 people have fled eastern DRC to neighboring countries since January 2025. NPR reports that at least 7 million people are displaced in eastern Congo, a broader figure that may include internal displacement.

Still Unclear

• The death rate estimate of 30-50% reported by the Guardian is attributed to a WHO official. (Single-source claim from The Guardian)
• The first confirmed recovery from the outbreak occurred on May 27, according to the Guardian. (Single-source claim from The Guardian)
• The CREID research network, funded by the NIH, was halted in 2025 due to funding cuts by the Trump administration, preventing researchers from supporting the outbreak response, as reported by Ars Technica. (Single-source claim from Ars Technica)
• Kenya’s high court temporarily suspended plans for a US quarantine facility for Ebola patients, as reported by the Guardian. (Single-source claim from The Guardian)
• Clinical trials for a vaccine could be ready by the end of the year, according to the head of the African Union’s health agency, as reported by the Guardian. (Single-source claim from The Guardian)
• Health workers in some areas have resorted to using expired medical masks, as reported by NPR. (Single-source claim from NPR)

Misconceptions

No widespread misconceptions addressed in the sources.

Key Figures

• Tedros Adhanom Ghebreyesus, Director-General of the World Health Organization
• Anaïs Legand, WHO high threat pathogens team member
• Jean Kaseya, head of the African Union’s health agency
• Marco Rubio, US Secretary of State
• Kristian Andersen, evolutionary virologist at Scripps Research
• Robert Garry, professor of microbiology and immunology at Tulane Medical School

Sources: The Guardian, NPR, Ars Technica